A new research paper was published in Aging, entitled, “Deciphering reproductive aging in women using a NOD/SCID mouse model for distinct physiological ovarian phenotypes.” Female fertility is negatively correlated with age, with noticeable declines in oocyte quantity and quality until menopause. To understand this physiological process and evaluate human approaches for treating age-related infertility, preclinical studies in appropriate animal models are needed.
In this new study, researchers María Marchante, Noelia Ramirez-Martin, Anna Buigues, Jessica Martinez, Nuria Pellicer, Antonio Pellicer, and Sonia Herraiz from IVIRMA, University of Valencia, and Instituto Investigacion Sanitaria La Fe aimed to characterise an immunodeficient physiological ageing mouse model displaying ovarian characteristics of different stages during women’s reproductive life.
“The main purpose of our study was to establish a physiological ovarian-ageing mouse model that could be employed to evaluate potential therapeutic interventions derived from human origin.”
NOD/SCID mice of different ages (8, 28, and 36–40 weeks old) were employed to mimic ovarian phenotypes of young, advanced maternal age (AMA), and old women (~18–20, ~36–38, and over 45 years old, respectively). Mice were stimulated, mated, and sacrificed to recover oocytes and embryos. Then, ovarian reserve, follicular growth, ovarian stroma, mitochondrial dysfunction, and proteomic profiles were assessed. Age-matched C57BL/6 mice were employed to cross-validate the reproductive outcomes.
The quantity and quality of oocytes were decreased in AMA and old mice. These age-related effects associated spindle and chromosome abnormalities, along with decreased developmental competence to blastocyst stage. Old mice had less follicles, impaired follicle activation and growth, an ovarian stroma inconducive to growth, and increased mitochondrial dysfunctions. Proteomic analysis corroborated these histological findings. Based on that, NOD/SCID mice can be used to model different ovarian ageing phenotypes and potentially test human anti-ageing treatments.
“In summary, in this study we characterised the quality of the ovarian microenvironment and reproductive outcomes of an immunodeficient murine model of physiological ovarian ageing by evaluating fertility outcomes, ovarian reserve and stroma, mitochondrial dysfunctions, and the ovarian proteome at different stages. This model adequately mimicked the characteristics of the reproductive stages in women, without external agents compromising folliculogenesis, or disrupting molecular mechanisms and ovarian function, which could mask the processes of physiological ageing.”
